Cancer Network spoke with Charles Shapiro, MD, about the USPSTF's stance on use of tamoxifen, raloxifene, and aromatase inhibitors to prevent breast cancer.
Charles Shapiro, MD
Advertisement
Articles by Charles Shapiro, MD
Advertisement
Latest Updated Articles
Role of Chemopreventive Agents in Women at Increased Risk for Breast CancerPublished: March 18th 2019 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
ESMO 2025: Key Anticipated Updates in Breast and Lung Tumors
2
Tucatinib Regimen Improves PFS in HER2+ Metastatic Breast Cancer
3
Ficerafusp Alfa/Pembrolizumab Receives FDA BTD in Front-Line HNSCC
4
Taking Stock of Immune Effector Cell Therapy Developments in GI Cancers
5
